Hematology TimesFDA puts drug on fast track to treat secondary AMLJanuary 22, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesDrug can increase survival in poor-risk AMLJanuary 14, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesStudy reveals potential strategy to treat AMLJanuary 13, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesCertain cancers primarily result from ‘bad luck’January 3, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesAMLNon-Hodgkin Lymphoma
Hematology TimesStudy confirms IDH2 as therapeutic target in AML, MDSDecember 18, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsVALOR: Baby step forward or misstep in AML?December 16, 2014AMLTransfusion MedicineCellular Therapy
Hematology TimesDiscovery could help predict, prevent therapy-related AMLDecember 12, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFirst randomized evidence for kinase inhibitor use in AMLDecember 11, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesMore isn’t always better with daunorubicin induction in AMLDecember 10, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesCLL drug can fight AML too, study suggestsDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
Hematology TimesFinding could help docs tailor treatment for myeloid leukemiasDecember 9, 2014Leukemia, Myelodysplasia, TransplantationAMLCML
Oncology PracticeSorafenib boosts event-free survival of adult AMLDecember 8, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesBreast cancer drug could treat MPNs, AMLDecember 5, 2014CythemiasLeukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA grants drug orphan designation for AMLDecember 3, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
